Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative medications operate by mimicking the inherent actions of GLP-1, a hormone produced by https://nanafgrb346819.blog5star.com/39425968/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes